<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03505593</url>
  </required_header>
  <id_info>
    <org_study_id>NUTRI002</org_study_id>
    <nct_id>NCT03505593</nct_id>
  </id_info>
  <brief_title>Feasibility Study to Evaluate Safety of ENvizion Medical™ ENVUE™ System</brief_title>
  <official_title>A Feasibility Study to Evaluate the Clinical Safety of ENvizion Medical™ Enteral Feeding Tube Placement Using the ENvizion Medical™ ENVUE™ System in Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Envizion Medical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Envizion Medical Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center, non-randomized feasibility clinical evaluation that is designed to&#xD;
      affirm the safety of the ENVUE™ System guidance during the placement of the ENvizion Medical™&#xD;
      enteral feeding tubes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enteral nutrition is the preferred route for the provision of nutritional support in most&#xD;
      critical ill patients with functional gastrointestinal tract. Achieving early enteral&#xD;
      nutrition (EN) in critically ill patients is associated with fewer major complications,&#xD;
      reduced mortality and length of hospital stay, and significant cost savings. It is estimated&#xD;
      that approximately 1.2 million feeding tubes are placed blindly each year in the United&#xD;
      States alone. Despite the obvious advantages of the enteral tube feeding, inadvertent&#xD;
      placement of Enteral Feeding Tube (EFT) into the airway is relatively common and can result&#xD;
      in significant pulmonary injury including pneumothorax and pneumonia. Airway misplacement&#xD;
      occurs in 1.2- 4 % of blind EFT insertions, with 0.2 to 1.2% of all the feeding tube&#xD;
      placements cause pulmonary complications to patients. The gold standard for detecting&#xD;
      inadvertent placement of a feeding tube in the lungs is radiography. However, because of its&#xD;
      cost, possible delay of feedings while waiting for radiography, and risk for radiation&#xD;
      exposure, clinicians continue to seek for alternative methods to confirm correct placement.&#xD;
&#xD;
      All the above mentioned, emphasizes the fact that safe and effective delivery of nasoenteral&#xD;
      tube feedings requires assurance that the feeding tube tip is in a proper position. The&#xD;
      ENVUE™ System is an electromagnetic tracking system which tracks the path of the feeding tube&#xD;
      during placement. The benefit of the system when EFT is misdirected into the pulmonary system&#xD;
      is a real-time visual tracing, which may prompt users to withdraw the tube and reinsert it.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 28, 2018</start_date>
  <completion_date type="Actual">August 9, 2018</completion_date>
  <primary_completion_date type="Actual">August 9, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Successfully Placed Enteral Feeding Tube</measure>
    <time_frame>During procedure visit</time_frame>
    <description>Enteral tube (EFT) can be placed in the correct anatomical position without occurrence of guidance-related adverse events.&#xD;
Procedure success was evaluated by comparing tube tip location according to the ENVUE System and abdominal and/or thoracic X-Ray.&#xD;
Guidance-related AEs were evaluated through the documentation of any guidance-related serious adverse events (SAE) or adverse events (AE) occurring during a subject's participation in the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Number of Placement Attempts</measure>
    <time_frame>During procedure visit</time_frame>
    <description>Number of placement attempts was evaluated by number of replacement and repositioning events, as defined below:&#xD;
Replacement: Complete removal of the tube from the patient or retraction above the level of the pharynx followed by reinsertion&#xD;
Repositioning: Changing position of tube without complete removal of the tube</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Retrograde Tube Migration Events</measure>
    <time_frame>During follow-up visit (20-48 hours post tube placement)</time_frame>
    <description>Tube Migration was defined as: Retrograde migration from desired placement position.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Enteral Nutrition</condition>
  <arm_group>
    <arm_group_label>EFT placement using ENVUE System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placement of the ENvizion Medical™ Enteral Feeding Tube (EFT) in the stomach or small intestine of adult patients who require feedings via the oro/ nasoenteric route, using the ENVUE™ System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ENVUE System</intervention_name>
    <description>The ENvizion Medical™ ENVUE™ System is designed to aid qualified operators in the placement of the ENvizion Medical™ Enteral Feeding Tube™ into the stomach or small intestine.</description>
    <arm_group_label>EFT placement using ENVUE System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must be &gt;21 years of age&#xD;
&#xD;
          -  Patients must require placement of an enteral feeding tube&#xD;
&#xD;
          -  Patients have an endotracheal tube, OR Do not have an endotracheal tube but are&#xD;
             sedated (RASS score of -2 or less) and/or obtunded (Glasgow Coma scale of 9-12)&#xD;
&#xD;
          -  Patients or legal authorized representative must be able to understand and adhere to&#xD;
             all protocol procedures and be willing and able to provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients must not have a history of:&#xD;
&#xD;
               -  Esophageal varices or ulcers&#xD;
&#xD;
               -  Upper airway obstruction&#xD;
&#xD;
               -  Upper GI stenosis or obstruction&#xD;
&#xD;
               -  Trauma involving sinuses, nares face or neck that would prevent nasogastric (NG)&#xD;
                  or oral tube insertion&#xD;
&#xD;
               -  Deformities of the sinus cavities and/or skull base&#xD;
&#xD;
               -  Esophageal cancer or neoplasm&#xD;
&#xD;
          -  Patients must not have a significant concomitant illness that would adversely affect&#xD;
             their participation in the study&#xD;
&#xD;
          -  Female patients who are pregnant or lactating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lewis Jacobson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St.Vincent Hospital and Health Care Center, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St.Vincent Hospital and Health Care Center, Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 9, 2018</study_first_submitted>
  <study_first_submitted_qc>April 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2018</study_first_posted>
  <results_first_submitted>August 9, 2020</results_first_submitted>
  <results_first_submitted_qc>August 23, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 10, 2020</results_first_posted>
  <last_update_submitted>August 23, 2020</last_update_submitted>
  <last_update_submitted_qc>August 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 11, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/93/NCT03505593/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of 48 enrolled participants, 46 met inclusion/ exclusion criteria and underwent a tube placement attempt. From these 46 participants, 43 completed a successful tube placement.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>EFT Placement Using ENVUE System</title>
          <description>Placement of the ENvizion Medical™ Enteral Feeding Tube (EFT) in the stomach or small intestine of adult patients who require feedings via the oro/ nasoenteric route, using the ENVUE™ System.&#xD;
ENVUE System: The ENvizion Medical™ ENVUE™ System is designed to aid qualified operators in the placement of the ENvizion Medical™ Enteral Feeding Tube™ into the stomach or small intestine.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Died before procedure</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Anatomical abnormality</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unable to pass through esophagus</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Obstruction by Endotracheal tube</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>EFT Placement Using ENVUE System</title>
          <description>Placement of the ENvizion Medical™ Enteral Feeding Tube (EFT) in the stomach or small intestine of adult patients who require feedings via the oro/ nasoenteric route, using the ENVUE™ System.&#xD;
ENVUE System: The ENvizion Medical™ ENVUE™ System is designed to aid qualified operators in the placement of the ENvizion Medical™ Enteral Feeding Tube™ into the stomach or small intestine.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" lower_limit="28" upper_limit="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sedated</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Obtunded</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Endotracheal Tube</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Successfully Placed Enteral Feeding Tube</title>
        <description>Enteral tube (EFT) can be placed in the correct anatomical position without occurrence of guidance-related adverse events.&#xD;
Procedure success was evaluated by comparing tube tip location according to the ENVUE System and abdominal and/or thoracic X-Ray.&#xD;
Guidance-related AEs were evaluated through the documentation of any guidance-related serious adverse events (SAE) or adverse events (AE) occurring during a subject's participation in the study.</description>
        <time_frame>During procedure visit</time_frame>
        <population>Subjects who underwent a successful feeding tube placement using the ENvue system</population>
        <group_list>
          <group group_id="O1">
            <title>EFT Placement Using ENVUE System</title>
            <description>Placement of the ENvizion Medical™ Enteral Feeding Tube (EFT) in the stomach or small intestine of adult patients who require feedings via the oro/ nasoenteric route, using the ENVUE™ System.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Successfully Placed Enteral Feeding Tube</title>
          <description>Enteral tube (EFT) can be placed in the correct anatomical position without occurrence of guidance-related adverse events.&#xD;
Procedure success was evaluated by comparing tube tip location according to the ENVUE System and abdominal and/or thoracic X-Ray.&#xD;
Guidance-related AEs were evaluated through the documentation of any guidance-related serious adverse events (SAE) or adverse events (AE) occurring during a subject's participation in the study.</description>
          <population>Subjects who underwent a successful feeding tube placement using the ENvue system</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Number of Placement Attempts</title>
        <description>Number of placement attempts was evaluated by number of replacement and repositioning events, as defined below:&#xD;
Replacement: Complete removal of the tube from the patient or retraction above the level of the pharynx followed by reinsertion&#xD;
Repositioning: Changing position of tube without complete removal of the tube</description>
        <time_frame>During procedure visit</time_frame>
        <population>43 subjects underwent a successful feeding tube placement using the ENvue system. In total, 44 tubes were successfully placed- 1 subject pulled the tube out and a new tube was placed instead</population>
        <group_list>
          <group group_id="O1">
            <title>EFT Placement Using ENVUE System</title>
            <description>Placement of the ENvizion Medical™ Enteral Feeding Tube (EFT) in the stomach or small intestine of adult patients who require feedings via the oro/ nasoenteric route, using the ENVUE™ System.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Placement Attempts</title>
          <description>Number of placement attempts was evaluated by number of replacement and repositioning events, as defined below:&#xD;
Replacement: Complete removal of the tube from the patient or retraction above the level of the pharynx followed by reinsertion&#xD;
Repositioning: Changing position of tube without complete removal of the tube</description>
          <population>43 subjects underwent a successful feeding tube placement using the ENvue system. In total, 44 tubes were successfully placed- 1 subject pulled the tube out and a new tube was placed instead</population>
          <units>Number of placement attempts</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Retrograde Tube Migration Events</title>
        <description>Tube Migration was defined as: Retrograde migration from desired placement position.</description>
        <time_frame>During follow-up visit (20-48 hours post tube placement)</time_frame>
        <population>43 subjects underwent a successful feeding tube placement using the ENvue system.&#xD;
Of the Forty- three (43) subjects that completed a successful placement procedure, thirty-six (36) subjects underwent a successful tube tip position check at follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>EFT Placement Using ENVUE System</title>
            <description>Placement of the ENvizion Medical™ Enteral Feeding Tube (EFT) in the stomach or small intestine of adult patients who require feedings via the oro/ nasoenteric route, using the ENVUE™ System.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Retrograde Tube Migration Events</title>
          <description>Tube Migration was defined as: Retrograde migration from desired placement position.</description>
          <population>43 subjects underwent a successful feeding tube placement using the ENvue system.&#xD;
Of the Forty- three (43) subjects that completed a successful placement procedure, thirty-six (36) subjects underwent a successful tube tip position check at follow-up visit.</population>
          <units>Number of tube retrograde migration</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From the participant's tube placement procedure (day 0) to the end of of the follow-up visit (20-48 hours post tube placement)</time_frame>
      <desc>Analysis was performed on all enrolled subjects (48 subjects)</desc>
      <group_list>
        <group group_id="E1">
          <title>EFT Placement Using ENVUE System</title>
          <description>Placement of the ENvizion Medical™ Enteral Feeding Tube (EFT) in the stomach or small intestine of adult patients who require feedings via the oro/ nasoenteric route, using the ENVUE™ System.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="48"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Enteral feeding tube distal tip deattachement</sub_title>
                <description>Between the feeding tube placement procedure and follow-up visit, the tip of the tube became detached from the rest of the tube. The tip tube left the patient's body in a natural manner (during bowel movements).</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Twelve months following the completion of the study, Investigator may publish the results of the study. Investigator shall provide sponsor advanced copies of any proposed publication sixty days prior to planned publication Sponsor will have sixty days to review the proposed publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Director</name_or_title>
      <organization>ENvizion Medical</organization>
      <phone>+972-72-2288240</phone>
      <email>anath@envizionmed.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

